Astrid Ammendola Selected Research

(1- (1- ((2,4- dioxoimidazolidin- 1- ylimino)methyl)- 2- phenylethylcarbamoyl)- 2- (1H- indol- 3- yl)ethylcarbamoyl)- 2- (1H- indole)

3/2009

The peptide-semicarbazone S-2209, a representative of a new class of proteasome inhibitors, induces apoptosis and cell growth arrest in multiple myeloma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Astrid Ammendola Research Topics

Disease

1	Melanoma (Melanoma, Malignant) 11/2019
1	Neoplasms (Cancer) 11/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Vomiting 01/2019
1	Anemia 01/2019
1	Nausea 01/2019
1	Fatigue 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Multiple Myeloma 03/2009
1	Body Weight (Weight, Body) 03/2009

Drug/Important Bio-Agent (IBA)

2	Histone Deacetylases (Histone Deacetylase)IBA 11/2019 - 01/2019
2	Histone Deacetylase InhibitorsIBA 11/2019 - 01/2019
1	domatinostatIBA 11/2019
1	pembrolizumabIBA 11/2019
1	AntigensIBA 11/2019
1	RNA (Ribonucleic Acid)IBA 11/2019
1	resminostatIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	EnzymesIBA 03/2009
1	Peptides (Polypeptides)IBA 03/2009
1	(1- (1- ((2,4- dioxoimidazolidin- 1- ylimino)methyl)- 2- phenylethylcarbamoyl)- 2- (1H- indol- 3- yl)ethylcarbamoyl)- 2- (1H- indole)IBA 03/2009
1	SemicarbazonesIBA 03/2009
1	Proteasome InhibitorsIBA 03/2009
1	CreatinineIBA 03/2009

Therapy/Procedure

1	Immunotherapy 11/2019
1	Therapeutics 11/2019